drugset / Trial / NCT04825678
A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine
NaSingle-groupOpen-labelHealth-services research
Summary
The main purpose of this study is to evaluate the effect of erenumab on medication-specific treatment satisfaction.
Timeline
- Start
- 2021-06-11
- Primary completion
- 2023-09-28
- Completion
- 2023-09-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Erenumab | Monoclonal antibody | — | Subcutaneous |